Skip to content

Insights

Thought Leadership

GATC Health represents a collective of influential voices across a breadth of fields and professions. These are their directional stories and ideas.

AI-Derived Therapeutic Development for the Treatment of Opioid Use Disorder

Biosimilar trial failed? Investors get their money back: a new insurance model redefines clinical trial financing

Autologous Antigen-Specific Immunotherapy (AASI): Precision Immune Re-education in Autoimmunity and Beyond

Peptide Neuromodulation in Autism Spectrum Disorder: Targeting Neuroinflammation, Mitochondrial Dysfunction, and Synaptic Plasticity

Restoring the Degenerating Brain: Mesenchymal and Neural Stem Cells in Neurotherapeutics

AI-Driven Drug Development: A Capital-Efficient Model for the Future of Precision Medicine

Benefits and Risks of Stem Cells: A Comprehensive Review

Short-Peptides May be the Key to Long Life

Multiomics Experimental Design for Drug Discovery

Spinner